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Abstract
Background  and  objective:  Lymphadenopathy  is  a  common  medical  problem.  A  lymph
node  biopsy  may  be  necessary  for  deﬁnitive  diagnosis  in  selected  cases.
Methods:  The  study  group  included  a  retrospective,  hospital-based  series  of  patients
who  had  a  cervical  lymph  node  biopsy  at  the  Saudi  Aramco  Medical  Services  organi-
zation  between  1997  and  2008.
Results:  During  the  study  period,  there  were  a  total  of  452  cervical  lymph  node
biopsies.  Biopsies  were  performed  on  122  (27%)  children  ≤18  years  and  81  (18%)
patients  >60  years.  The  most  common  histopathological  diagnosis  was  reactive  dis-
ease  (52.2%,  n  =  236),  which  was  followed  by  granulomatous  disease  (15.5%,  n  =  70).
We  detected  carcinoma  in  14.6%  of  the  patients  (n  =  66),  Hodgkin’s  lymphoma  in  8.8%
(n  =  40)  and  non-Hodgkin’s  disease  in  8.8%  (n  =  40).  Malignancy  was  more  common  in
adults  than  children  (19.5%  vs.  1.6%,  respectively  and  reactive  disease  was  more
common  in  children  than  adults  (65.3%  vs.  47.3%,  respectively).  Metastatic  disease
was  more  likely  in  the  older  age  group  (17.7%  vs.  0%),  Hodgkin’s  disease  was  found
in  12.5%  of  the  adolescents,  and  non-Hodgkin’s  disease  was  present  in  10.3%  of  the
adults  and  elderly.
Conclusion:  The  most  common  histopathological  ﬁndings  for  cervical  lymph  node
biopsies  in  eastern  Saudi  Arabia  were  reactive  disease  and  granulomatous  disease.
©  2011  King  Saud  Bin  Abdulaziz  University  for  Health  Sciences.  Published  by  Elsevier
Ltd.  All  rights  reserved.
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nd cervical  lymphadenopathy  in  particular  may
resent  in  56%  of  patients  examined  [1].  The  cause
 Sciences. Published by Elsevier Ltd. All rights reserved.
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Fig.  1  The  percentage  of  each  histopathological  diagno-
sis  observed  in  each  age  group.
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Dhe  analysis  of  pathological  ﬁndings  for  cervical  lym
f  lymphadenopathy  is obvious  in  many  patients
fter a  complete  history  is  taken  and  a  physi-
al examination  is  performed.  However,  laboratory
ests  and  lymph  node  biopsy  may  be  necessary  in
elected cases.  A  few  reports  have  addressed  the
auses  of  cervical  lymphadenopathy  in  Saudi  Arabia
2—4]. However,  these  studies  are  outdated,  and  we
herefore examined  the  histopathological  features
f cervical  lymphadenopathy  in  the  Saudi  Aramco
opulation.
ethods
he  Saudi  Aramco  Medical  Services  Organization
SAMSO) provides  medical  care  for  Saudi  Aramco
mployees and  their  dependents,  caring  for  approx-
mately  370,000  eligible  individuals.  The  main
ospital,  Dhahran  Health  Center  (DHC),  is  a  380-bed
eferral  institution  with  ﬁve  intensive  care  units.
dmissions  to  the  hospital  cover  a  wide  range  of
atients  and  include  patients  receiving  chemother-
py for  hematological  and  solid  organ  malignancies.
In this  study,  we  included  all  of  the  patients  who
resented  with  cervical  lymphadenopathy  from
997 to  2008  and  underwent  lymph  node  biopsy
t our  hospital.  We  excluded  those  patients  with
nown primary  cancer  and  those  who  had  a  biopsy
s a  staging  procedure  for  a  known  malignancy.
e included  the  demographic  data  and  the  ﬁnal
istopathological  diagnosis  for  each  patient.  Lymph
ode biopsies  were  performed  on  the  patients  who
ad displayed  lymphadenopathy  for  longer  than  4
eeks; these  cases  were  considered  chronic  lym-
hadenopathy  [5,6],  and  the  biopsy  was  performed
hen the  lymph  node  measured  greater  than
.5 cm.  Lymph  node  specimens  were  ﬁxed  in  10%
uffered  formaldehyde  and  processed  in  parafﬁn.
outine staining  with  hematoxylin—eosin  was  per-
ormed,  and  special  staining  with  Ziehl—Neelsen,
eticulin, Gomori—Methenamine  silver  and  Periodic
cid  Schiff  (PAS)  was  performed  when  indicated.
he mycobacterial  cultures  were  set  up  in  the
ycobacteriology  laboratory  of  SAMSO  using  the
onventional  Lewes-Johnson  media  [7].
esults
 total  of  569  patients  underwent  cervical  lymph
ode  biopsy  during  the  study  period.  We  excluded
17 patients  because  they  were  known  to  have
rimary cancer  or  had  the  biopsy  performed  as
 staging  procedure  for  a  known  malignancy.  The
emaining  452  patients  were  included  in  the  ﬁnal
T
o
aediatric  (age  <  13  years),  adolescent  (age  13—19  years),
dult  (age  20—60  years)  and  older  adult  (age  >  61).
nalysis.  The  mean  age  was  36.7  ±  1  years,  and
3.7% (n  =  243)  of  the  patients  were  females  and
6.3% (n  =  209)  were  males.  The  patients  were  clas-
iﬁed as  children  (age  < 13  years),  adolescents  (age
3—19 years),  adults  (age  20—60  years)  and  older
dults (age  ≥  61).  There  were  69  (15.3%)  children,
4 (16.4%)  adolescents,  229  (50.6%)  adults  and  80
17.7%) older  adults.  The  histological  diagnoses  by
ex and  age  group  are  shown  in  Table  1.
The most  common  histopathological  diagnosis
as reactive  disease  (52.2%,  n  = 236),  followed  by
ranulomatous  disease  (15.5%,  n =  70)  (Table  1).
e detected  carcinoma  in  14.6%  of  the  patients
n = 66),  Hodgkin’s  lymphoma  in  8.8%  (n  =  40)  and
on-Hodgkin’s  disease  in  8.8%  (n  =  40)  (Fig.  1).
alignancy  was  more  common  in  older  adults  (25%
s. 6.8%  in  children  and  17.9%  in  adults),  and  reac-
ive disease  was  more  common  in  those  less  than
0 years  of  age  (∼61%)  than  in  older  adults  (21.3%)
Fig.  1).  Mycobacterium  tuberculosis  was  cultured
rom  38.8%  of  patients  with  granulomatous  lym-
hadenitis.  Carcinoma  was  diagnosed  in  66  (14.6%)
f the  cases,  Hodgkin’s  disease  was  found  in  12.5%
f the  adolescent  cases,  non-Hodgkin’s  disease  was
resent in  40  (8.8%)  of  the  patients,  and  granu-
omatous disease  was  the  diagnosis  for  70  (15.5%)
atients.
iscussionhe  initial  approach  to  determining  the  cause
f peripheral  lymphadenopathy  includes  taking
 thorough  history  and  performing  a physical
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xamination.  However,  if  the  initial  investigation
oes not  reveal  the  cause  of  lymphadenopathy  and
he lymph  node  swelling  persists  beyond  4  weeks,
hen  a biopsy  is  the  best  way  to  reach  a deﬁnitive
iagnosis. Excisional  biopsy  of  the  most  abnormal
ode  is  the  best  approach  to  enable  the  pathologist
o determine  a diagnosis  [6].  Other  investigators
ave proposed  a  prediction  rule  to  determine  which
atients  require  a lymph  node  biopsy  [8].  Exact
easurement  of  the  lymph  node  at  which  a  biopsy
s indicated  is  variable  among  different  studies.
ymph  nodes  >1  cm  were  considered  abnormal  in
ne study,  and  >2  cm  in  diameter  was  regarded  as
eing clinically  signiﬁcant  in  another  study  [9].
The mean  age  of  the  patients  in  the  current
tudy was  36.7  ±  1  years.  This  mean  age  is similar
o that  found  in  previous  studies  in  Saudi  Arabia
2,3]. These  studies  included  all  age  groups;  how-
ver, other  studies  have  included  adult  patients
nly [4].  In  a study  from  Jordan,  35%  of  the  lymph
odes  excised  revealed  malignant  lymphoma,  and
0.5% revealed  metastatic  deposits  [10].  A  compar-
son of  the  different  studies  is  shown  in  Table  2.  In  a
tudy from  Al-Khobar,  Saudi  Arabia,  in  1982—1983,
2% of  the  biopsies  revealed  either  primary  or
etastatic  malignant  conditions  [11].  In  the  current
tudy, metastatic  disease  was  found  more  often
n the  older  age  group  (17.7%  vs.  0%).  This  ﬁnd-
ng is  in  agreement  with  those  of  other  studies
4]. Thus,  the  etiology  of  cervical  lymphadenopa-
hy is  variable  according  to  the  age  of  the  patients
Table  2).  In  our  study,  reactive  lymphadenitis  was
he most  common  etiology,  similar  to  the  results
f studies  that  included  children  [9,12—14].  This
nding  is  likely  related  to  the  inclusion  of  pedi-
tric patients,  as  they  constituted  approximately
0% of  the  cases  in  the  current  study.  The  inclusion
f pediatric  patients  in  our  study  is  in  contrast  to
he study  by  Abba  [4],  which  included  only  adult
atients  and  found  that  13%  of  the  cases  were  due
o reactive  disease.  The  inclusion  of  children  with
 lymphadenopathy  of  2 weeks  duration  resulted
n a  higher  rate  of  patients  (70%)  having  benign
ymph node  enlargement  [5].  Another  explanation
or the  high  rate  of  reactive  lymphadenopa-
hy that  we  found  is  the  exclusion  of  patients
ith malignancy  from  the  analysis  in  the  current
tudy.
In a study  from  Saudi  Arabia,  granulomatous  lym-
hadenopathy  due  to  tuberculosis  was  the  most
requent  cause  (37.9%)  observed,  followed  by  lym-
homa (32.9%)  [4].  In  another  study,  30%  of  lymph
odes exhibited  non-speciﬁc  reactive  changes,  and
ranulomatous  conditions  accounted  for  28%  of
he cases  [10].  In  a third  study,  granulomatous
ymphadenitis  was  the  most  common  cause  (43%)
The  analysis  of  pathological  ﬁndings  for  cervical  lymph  
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dentiﬁed  [3].  In  the  current  study,  the  most  com-
on histopathological  cause  of  lymphadenopathy
as reactive  disease  (52.2%),  followed  by  granu-
omatous  disease  (15.5%).  The  difference  between
hese studies  is  probably  related  to  the  inclu-
ion of  only  admitted  patients  in  the  former  study
4]. M.  tuberculosis  was  cultured  from  38.8%  of
he patients  with  granulomatous  lymphadenitis  in
he current  study.  Similarly,  granulomatous  lym-
hadenopathy  due  to  tuberculosis  was  the  most
requent  diagnosis  (37.9%)  observed  in  one  study
rom Saudi  Arabia  [4].  In  another  study,  granulo-
atous conditions  accounted  for  28%  of  the  cases
10]. However,  that  study  did  not  speciﬁcally  iden-
ify the  granulomas  as  positive  for  tuberculosis.
hus, granulomatous  lymphadenitis  is  a common
ause of  cervical  lymphadenopathy,  and  M.  tuber-
ulosis  causes  a  signiﬁcant  number  of  cases  in
ur region.  Moreover,  granulomatous  lymphadenitis
as shown  to  be  a  common  cause  (36.3%)  of  child-
ood lymphadenitis  in  developing  countries  [9],  and
uberculous  lymphadenitis  was  conﬁrmed  in  332  of
he 484  patients  exhibiting  chronic  granulomatous
hanges (25%)  in  that  study  [9].  There  is  a geograph-
cal variation  in  the  incidence  of  M.  tuberculosis
solated from  cervical  lymph  node  biopsies.  In  an
arly study,  M.  tuberculosis  was  found  to  be  the
ominant  cause  of  mycobacterial  cervical  adenitis
n adults,  whereas  other  mycobacteria  were  the
ause of  most  cases  of  cervical  adenitis  in  chil-
ren [15].  In  developed  regions  such  as  Australia,
urope, and  North  America,  granulomatous  lym-
hadenitis  is  usually  caused  by  a mycobacterium
ther than  tuberculosis  [15—17].  Consistent  with
revious  studies  from  Saudi  Arabia,  Hodgkin’s  dis-
ase accounted  for  8.7%  of  all  lymphadenopathies
n our  study  [3,11,18]. However,  one  study  from  a
ertiary referral  center  found  that  Hodgkin’s  dis-
ase was  observed  in  approximately  33%  of  cases,  a
gure that  is  much  higher  than  previously  reported
4]. Carcinoma  was  the  second  most  common  ﬁnd-
ng in  adults.  This  ﬁnding  is  in  agreement  with  other
tudies [3,19].
In  conclusion,  the  cervical  lymphadenopa-
hy biopsies  investigated  in  this  study  revealed
hat non-speciﬁc  reactive  hyperplasia  was  the
ost common  form  of  lymphadenopathy,  followed
y granulomatous  disease.  M.  tuberculosis  was
ultured  from  38.8%  of  the  granulomatous  lym-
hadenitis  cases  in  this  study.ompeting interests
one  declared.
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